⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001388139

Babich John W

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

6

Companies

1

Filings

4

CIK

0001388139

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2009-08-11	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, Exec. VP, CSO and Pres. of R&D	AAward	+50K sh	—	—	50,000
2009-05-12	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, Exec. VP, CSO and Pres. of R&D	AAward	+200K sh	—	—	200,000
2007-11-30	Molecular Insight Pharmaceuticals, Inc.P Purchase	Director, Exec. VP, CSO and Pres. of R&D	PPurchase	+600 sh	$8.34	+$5,004	171,635
2007-11-30	Molecular Insight Pharmaceuticals, Inc.P Purchase	Director, Exec. VP, CSO and Pres. of R&D	PPurchase	+1,900 sh	$8.35	+$15.9K	173,535
2007-02-01	Molecular Insight Pharmaceuticals, Inc.C Conversion	Director, Exec. VP, CSO and Pres. of R&D	CConversion	+27.7K sh	—	—	27,702
2007-02-01	Molecular Insight Pharmaceuticals, Inc.Series A Convertible Preferred StockC Conversion	Director, Exec. VP, CSO and Pres. of R&D	CConversion	−641 sh	—	—	0

Recent filings

4

Accepted (ET)
Aug 124
Babich John W0001209191-09-040403
SEC(opens sec.gov)
May 144
Babich John W0001209191-09-026740
SEC(opens sec.gov)
Dec 44
Molecular Insight Pharmaceuticals, Inc.0001209191-07-067597
SEC(opens sec.gov)
Feb 54
Molecular Insight Pharmaceuticals, Inc.0001209191-07-007511
SEC(opens sec.gov)

Companies

1

Molecular Insight Pharmaceuticals, Inc.Director, Exec. VP, CSO and Pres. of R&D

Address

MOLECULAR INSIGHT PHARMACEUTICALS, INC. 160 SECOND STREET

CAMBRIDGE, MA, 02142